Alejandra Carvajal, SVP, Chief Legal Officer at Mersana Therapeutics, Inc. (MRSN), sold 3,944 shares at $3.89 ($15K) on 2023-04-27, disclosed to the SEC on 2023-04-28.
Scheduled sale ($15k) by SVP, Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| MRSN | SELL | 2025-01-15 | $2K | — | Filing → |
| MRSN | SELL | 2024-10-07 | $27K | — | Filing → |
| MRSN | SELL | 2024-01-17 | $12K | — | Filing → |